Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Cabozantinib

Australian Public Assessment Report

AusPAR

AusPAR: Cabozantinib [PDF, 1.08 MB]

AusPAR: Cabozantinib [Word, 1.39 MB]

Attachment: Product Information: Cabozantinib [PDF, 318.11 KB]

Attachment: Product Information: Cabozantinib [Word, 126.61 KB]

Attachment: Extract from Clinical Evaluation: Cabozantinib [PDF, 4.44 MB]

Attachment: Extract from Clinical Evaluation: Cabozantinib [Word, 6.69 MB]

Device/Product Name

Cabometyx

Active ingredients

Cabozantinib

AusPAR Date

18 October 2018

Published

5 December 2018

Submission Number

PM-2016-04459-1-4

Submission Type

New chemical entity

Decision

Approved